Why is Jenburkt Pharma falling/rising?

As of 02-Sep, Jenburkt Pharmaceuticals Ltd. has experienced a price increase, currently standing at 1,154.90 with a change of 34.3, reflecting a rise of 3.06%. The stock has been gaining for the last three days, with a total return of 5.95% during this period. It outperformed its sector by 3.13% today. Despite a one-month decline of 9.67%, the stock has shown resilience with a year-to-date decrease of only 4.92%, while it has significantly outperformed the benchmark Sensex over the past three years and five years, with returns of 95.32% and 208.06%, respectively. There is no information available regarding positive or negative factors that might influence the stock's recent movement.
Broader market context indicates that, while Jenburkt Pharmaceuticals has seen a short-term gain, the Sensex has declined by 0.78% over the past week, suggesting that the stock's recent performance is relatively strong compared to the broader market. The stock's performance today, along with rising investor participation indicated by an increase in delivery volume, suggests a positive sentiment among investors, contrasting with the overall market trend.